[HTML] frontiersin.org

[HTML][HTML] Development of extracellular vesicle therapeutics: Challenges, considerations, and opportunities

B Claridge, J Lozano, QH Poh… - Frontiers in Cell and …, 2021 - frontiersin.org
Extracellular vesicles (EVs) hold great promise as therapeutic modalities due to their
endogenous characteristics, however, further bioengineering refinement is required to …
被引用次数：99 相关文章

Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities

B Claridge, J LOZANO SALGADO, QH Poh… - opal.latrobe.edu.au
Extracellular vesicles (EVs) hold great promise as therapeutic modalities due to their
endogenous characteristics, however, further bioengineering refinement is required to …

Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities

B Claridge, J Lozano, QH Poh… - Frontiers in cell and …, 2021 - pubmed.ncbi.nlm.nih.gov
Extracellular vesicles (EVs) hold great promise as therapeutic modalities due to their
endogenous characteristics, however, further bioengineering refinement is required to …

Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities.

B Claridge, J Lozano, QH Poh… - Frontiers in Cell and …, 2021 - europepmc.org
Extracellular vesicles (EVs) hold great promise as therapeutic modalities due to their
endogenous characteristics, however, further bioengineering refinement is required to …

Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities

B Claridge, J Lozano, QH Poh… - Frontiers in Cell and …, 2021 - cir.nii.ac.jp
抄録< jats: p> Extracellular vesicles (EVs) hold great promise as therapeutic modalities due
to their endogenous characteristics, however, further bioengineering refinement is required …
[HTML] nih.gov

[HTML][HTML] Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities

B Claridge, J Lozano, QH Poh… - Frontiers in Cell and …, 2021 - ncbi.nlm.nih.gov
Extracellular vesicles (EVs) hold great promise as therapeutic modalities due to their
endogenous characteristics, however, further bioengineering refinement is required to …
[PDF] archive.org

[PDF][PDF] Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities

B Claridge, J Lozano, QH Poh, DW Greening - scholar.archive.org
Extracellular vesicles (EVs) hold great promise as therapeutic modalities due to their
endogenous characteristics, however, further bioengineering refinement is required to …

Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities

B Claridge, J Lozano, QH Poh… - Extracellular Vesicles as …, 2022 - books.google.com
Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and
Opportunities Page 60 REVIEW published: 20 September 2021 doi: 10.3389/fcell …

Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities

B Claridge, J Lozano, QH Poh, DW Greening - 2021 - agris.fao.org
Extracellular vesicles (EVs) hold great promise as therapeutic modalities due to their
endogenous characteristics, however, further bioengineering refinement is required to …

Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities.

B Claridge, J Lozano, QH Poh… - Frontiers in Cell and …, 2021 - europepmc.org
Extracellular vesicles (EVs) hold great promise as therapeutic modalities due to their
endogenous characteristics, however, further bioengineering refinement is required to …